Generation of an immortalized mesenchymal stem cell line producing a secreted biosensor protein for glucose monitoring.
Diabetes is a chronic disease characterized by high levels of blood glucose. Diabetic patients should normalize these levels in order to avoid short and long term clinical complications. Presently, blood glucose monitoring is dependent on frequent finger pricking and enzyme based systems that analyz...
Main Authors: | Evangelia K Siska, Itamar Weisman, Jacob Romano, Zoltán Ivics, Zsuzsanna Izsvák, Uriel Barkai, Spyros Petrakis, George Koliakos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5614622?pdf=render |
Similar Items
-
The expanding universe of transposon technologies for gene and cell engineering
by: Ivics Zoltán, et al.
Published: (2010-12-01) -
Stem cell models of polyglutamine diseases and their use in cell-based therapies
by: Evangelia eSiska, et al.
Published: (2015-07-01) -
Glucose metabolite glyoxal induces senescence in telomerase-immortalized human mesenchymal stem cells
by: Larsen Simon, et al.
Published: (2012-03-01) -
Establishment of Immortalized Human Amniotic Mesenchymal Stem Cells
by: Zan Teng, et al.
Published: (2013-02-01) -
Generation of an immortalized mouse embryonic palatal mesenchyme cell line.
by: Katherine A Fantauzzo, et al.
Published: (2017-01-01)